1 / 64

Brazil Retail Pharmacy Market Analysis

This report presents a strategic analysis of the Brazil Retail Pharmacy Market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, main players, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about the Brazil Retail Pharmacy Market, and offers unmatched value, accuracy, and expert insights.

Insights10
Download Presentation

Brazil Retail Pharmacy Market Analysis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Sample Report Brazil Retail Pharmacy Market Analysis July 2024

  2. This report presents a strategic analysis of the Brazil Retail Pharmacy Market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, main players, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about the Brazil Retail Pharmacy Market, and offers unmatched value, accuracy, and expert insights.

  3. Report Scope Report Attribute Details Number of Pages 70-80 Base Year for Estimation 2023 Forecast Period 2024-2030 Market Overview, Size & Forecasting, Market Segmentation, Growth Factors and Trends, Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape, Reimbursement Scenario Report Coverage Quantitative Units Revenue in USD Million/Billion (Mn/Bn) Currency Conversion 1 Brazilian Real= 0.18 USD Research Approach Secondary Research (90%), Primary Research (10%) 3 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  4. Table of Content CONTENT PG. NO. 06-14 1. Market Overview 1.1 Retail Pharmacy Market Overview 1.2 Retail Pharmacy Market Overview: Global 1.3 Economic Overview: Brazil 1.4 Retail Pharmacy Market Overview: Brazil 1.5 Healthcare Overview: Brazil 1.6 Budge of Brazil Government for Public Insurance 1.7 Top Developments in Brazil 15-17 2. Supply Chain and Ethics in Retail Pharmacies 2.1 Supply Chain of Retail Pharmacies 2.2 Ethical Code of Conduct for Pharmacists 18-23 3. Market Size and Forecasting 3.1 Brazil Retail Pharmacy Market Size and Forecasts 4 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  5. Table of Content CONTENT PG. NO. 3.2 Snapshot of Retail Pharmacy Market Segmentation 3.2.1 Market Segmentation: By Product Type 3.2.2 Market Segmentation: By Distribution Channel 24-29 4. Market Dynamics 4.1 Market Growth Drivers 4.2 Market Growth Restraints 30-37 5. Competitive Landscape 5.1 Key Players in Brazil Retail Pharmacy Market 38-43 6. Regulatory and Reimbursement Landscape in Brazil 6.1 Regulatory Landscape in Brazil 6.2 Reimbursement Scenario in Brazil 6.3 Reimbursement Process 5 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  6. Brazil Retail Pharmacy Market Analysis 1. Market Overview

  7. 1.1 Retail Pharmacy Market Overview Retail Pharmacies are medical stores which provide patients with safe, effective, and affordable prescription and non-prescription medications for various health related purposes, in the most convenient and accessible method ▪ These pharmacies are considered the primary point of access for the individuals who are seeking medicines and general advice for well-being from the pharmacists ▪ Various roles and responsibilities of the retail pharmacy include: Accurately delivering the medications as per the prescription of the physician ▪ Verifying the prescription for accuracy and possible drug-drug incompatibilities ▪ Providing patients with all the necessary information for the effective and safe use of the medications ▪ Ensuring that all the medications are in compliance with the regulatory guidelines ▪ Adapting and innovating on a continuous basis to meet the evolving needs of patients in the healthcare system ▪

  8. 1.2 Retail Pharmacy Market Overview: Global (1/2) Global Population Aged 65 and Older (Mn) 41 Mn Deaths globally due to NCDs, equivalent to 74% 805 780 759 $92 Bn Generic prescription sales in the year 2024 737 712 687 663 639 618 597 $1.48 Tn Spending on medicines in the year 2022, expected to rise to $1.9 Tn by 2027 805 Mn Individuals aged 65 and older globally as of 2023 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 8 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  9. 1.2 Retail Pharmacy Market Overview: Global (2/2) Brazil Market ~$xx Bn Market Illustrative Illustrative 9 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  10. 1.3 Economic Overview: Brazil GDP of Brazil ($Mn) Population of Brazil (Mn) 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 Population Split (2024) Brazil is an aging country, as it’s median age is 33.6 years which is higher than global median age ▪ By Gender By Age Group Country's population’s global share is 2.69% and it is increasing at a rate of 0.52% Life expectancy of female is 79.3 years and for male it is 73.1 years Currently 88.4% of population is urban in Brazil Top 3 largest cities in Brazil are Sao Paulo, Rio de Janeiro, Salvador ▪ ▪ 0-14 49% Male Female 15-64 51% ▪ 65+ ▪ Illustrative Illustrative 10 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  11. 1.4 Retail Pharmacy Market Overview: Brazil Population Aged 65 and Older Brazil (Mn) 70% Brazilians suffer from atleast one chronic disease by the age of 60 $6.06 Bn Revenue generated from OTC products and $19.50 Bn from prescription products in 2023 22.1 Mn Population of people aged 65 years and older in 2023 $14.92 Bn Worth sales of pharmaceutical products at pharmacy channel in 2021 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 Illustrative Illustrative 11 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  12. 1.5 Healthcare Overview: Brazil Public Healthcare Private Healthcare Universal Coverage: Brazilian Health System (Sistema Único de Saúde) ensures universal right to comprehensive healthcare at all levels of complexity (primary, secondary, and tertiary) Complimentary: Private healthcare system in Brazil operates simultaneously with the public healthcare system, providing services to individuals with private health insurance ▪ ▪ Services: Private healthcare system offers numerous advantages compared to the public healthcare system including access to shorter waiting times, more comfortable facilities, access to a wider range of specialties and treatments, and more choices for hospitals and clinics Funding: Brazil’s decentralized, universal public health system is funded with tax revenues and contributions from federal, state, and municipal governments ▪ ▪ Services: There is wide range of services offered to the Brazilians including hospital, mental health, outpatient specialty, primary, and prescription drug coverage ▪ Cost: Private healthcare costs considers several factors such as the insurance plan, provider, and level of coverage ▪ Challenges: Drawbacks of the public healthcare system include long waiting times, overcrowding at health facilities, and limited availability of certain services ▪ 12 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  13. 1.6 Budget of Brazil Government for Public Insurance Proposed Budget By Category 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31 Outlays $769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633 In Billions Of Dollars Medicare 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7% As % Of GDP National Health Expenditures (NHE) grew 2.7% to $4.3 Tn in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP) ▪ Medicare spending grew 8.4% to $900.8 Bn in 2021, or 21% of total NHE ▪ Private health insurance spending grew 5.8% to $1,211.4 Bn in 2021, or 28% of total NHE ▪ Out of pocket spending grew 10.4% to $433.2 Bn in 2021, or 10% of total NHE ▪ Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 Bn, or 14% of total NHE ▪ Hospital expenditures grew 4.4% to $1,323.9 Bn in 2021, slower than the 6.2% growth in 2020 ▪ Physician and clinical services expenditures grew 5.6% to $864.6 Bn in 2021, slower growth than the 6.6% in 2020 ▪ Prescription drug spending increased 7.8% to $378.0 Bn in 2021, faster than the 3.7% growth in 2020 ▪ Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7% ▪ Illustrative Illustrative 13 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  14. 1.7 Top Developments in Brazil Latest Deals in Brazil Company Name Type Year Key Pointers Eurofarma is a well-established Brazilian multinational pharmaceutical company and is the leader in prescriptions and second in generic drugs. Laboratório Canonne, a Brazilian pharmaceutical company is known for its well-established brands like Valda pastilles and Fixaderme ▪ December, 2022 Acquisition Eurofarma acquired the assets of Laboratório Canonne in Brazil with deal value of $138 Mn which strengthened Eurofarma’s position in the OTC market, allowing them to offer a wider range of products to consumers. ▪ Bayer is a global pharmaceutical and life sciences company with a significant presence in Brazil and União Química Farmacêutica Nacional is a leading Brazilian pharmaceutical company with broad portfolio of pharmaceutical products ▪ March, 2021 Partnership Partnership has a deal value of asset transaction being $150 Mn. Bayer made the decision to sell Cancioneiro manufacturing plant to União Química ▪ Illustrative Illustrative 14 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  15. Brazil Retail Pharmacy Market Analysis 2. Supply Chain and Ethics in Retail Pharmacies

  16. 2.1 Supply Chain of Retail Pharmacies Wholesalers (Distributors) Manufacturers Retail Pharmacy Consumers Consumers in the retail pharmacies are patients who are seeking the medication for a particular disease ▪ Act as intermediaries between manufacturers and pharmacies with large warehouses for the secure storing of medications Manage the inventory to prevent overstocking or stockouts Manufacture, and package medications according to the strict quality control standards ▪ ▪ ▪ Verify the prescription details and check for potential drug interactions ▪ They drive the demand for the various prescription and the OTC medications within the supply chain ▪ This includes active ingredients, excipients, and final packaging of the drug product ▪ Purchase medicines from manufacturers in bulk quantities at a discounted price and distribute them to pharmacies in small quantities ▪ Provide patients with crucial information about proper medication use, dosage, and potential side effects ▪ Determine availability and pricing of drugs and influence initial supply chain setup ▪ Illustrative Illustrative 16 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  17. 2.2 Ethical Code of Conduct for Pharmacists A pharmacist promotes the good of every patient in a caring, compassionate, and confidential manner A pharmacist respects the covenantal relationship between the patients and the pharmacist A pharmacist respects the values and abilities of colleagues and other health professionals Ethical Code of Conduct for Pharmacists A pharmacist serves individual, community, and societal needs A pharmacist respects the autonomy and dignity of all the patients A pharmacist acts with honesty and integrity in professional relationships Illustrative Illustrative 17 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  18. Brazil Retail Pharmacy Market Analysis 3. Market Size and Forecasting

  19. 3.1 Brazil Retail Pharmacy Market Size and Forecasts Brazil Retail Pharmacy Market Forecast, 2023-2030 2023 2024F 2025F 2026F 2027F 2028F 2029F 2030F 2023 2024 2025 2026 2027 2028 2029 2030 Major Markets Patient ($Mn) 2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12 Brazil Patient Size ($Bn) 0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73 % of Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45% Global Market Size ($Bn) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937 Brazil Market Size ($Bn) 61 74 84 87 91 95 99 106 Illustrative Illustrative 19 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  20. 3.2 Snapshot of Brazil Retail Pharmacy Market Segmentation Product Type Distribution Channel Indication Prescription Independent Cardiology OTC Chain Oncology Nephrology Psychiatry Others In this section you will get an understanding of the segmentations which will cover the Brazil Retail Pharmacy Market ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Illustrative Illustrative 20 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  21. 3.2.1 Market Segmentation: By Product Type Brazil Retail Pharmacy Market Share, By Product Type (2023) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ ▪ OTC ▪ Prescription Illustrative Illustrative 21 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  22. 3.2.2 Market Segmentation: By Distribution Channel Brazil Retail Pharmacy Market Share, By Distribution Channel (2023) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ ▪ Chain ▪ Independent Illustrative Illustrative 22 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  23. 3.2.3 Market Segmentation: By Indication Brazil Retail Pharmacy Market Share, By Indication (2023) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Others Psychiatry Cardiology ▪ Endocrinology ▪ Nephrology Oncology Illustrative Illustrative 23 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  24. Brazil Retail Pharmacy Market Analysis 4. Market Dynamics

  25. 4. Snapshot Of Market Growth Drivers And Restraints 4.1.1 4.1.2 4.1.3 Increasing aging population contributes to the vulnerability of the elderly to many diseases Rising Prevalence of Communicable as well as Non- Communicable Diseases (NCDs) Technological Advancements leading to enhanced customer experience 4.2.1 4.2.2 High cost of medicines can face resistance from the patients 4.2.3 Unequal distribution of pharmacies in Brazil affecting the overall growth Stringent licensing procedures & compliance with regulatory bodies Illustrative Illustrative 25 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  26. 4.1 Market Growth Drivers 4.1.1 Increasing prevalence of any chronic disease such as cancer, hypertension, and diabetes along infectious communicable diseases is 43% in Brazil Individual Prevalence of Various Diseases (%) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Illustrative Illustrative 26 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  27. 4.1 Market Growth Drivers 4.1.2 Brazil is considered as an aging country marked by a median age of 33.6 higher than the global median age of 30.5 and a higher population aged 65 and above who are more susceptible to chronic health conditions Rising Geriatric Population (Mn) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 2010 2022 2030 Illustrative Illustrative 27 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  28. 4.1 Market Growth Drivers 4.1.3 Innovations such as online pharmacies and mobile health apps have improved the overall patient experience and have led to the increased demand of the pharmacy services Various Innovations in Retail Pharmacies Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Illustrative Illustrative 28 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  29. 4.2 Market Growth Restraints 4.2.1 Navigating through a stringent regulatory landscape can be challenging for licensing of retail pharmacies 4.2.2 High cost associated with certain medicines impacts the affordability and accessibility for patients 4.2.3 Unequal distribution of pharmacies can hinder the market expansion to its full potential Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ ▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ ▪ ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Our analysis will thoroughly investigate the key restraints that may significantly impact business operations and growth. Illustrative Illustrative 29 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  30. Brazil Retail Pharmacy Market Analysis 5. Competitive Landscape

  31. 5.2 Key Players in Brazil Retail Pharmacy Market Here is the list of top 10 companies which will cover in the final report ▪ 1 6 Each company will have slides for ▪ RD Saúde Farmácias Bom Preço Overview Key details Offerings Name of products Recent activities/ Press Coverage Distribution and Vendor Partners Mergers, Acquisitions and Collaboration Financials If there are specific companies that you would like to be included in the report, please let us know via email In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Illustrative Illustrative o o o o 2 7 Hyper Pharma Drogaria Pacheco o o o 3 8 Pague Menos Drogaria Araujo o ▪ 4 9 Drogaria São Paulo Drogaria Carrefour ▪ 10 5 Farmácias Nissei Panvel Farmácias 31 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  32. 5.2.1 RD Saúde Offerings Founded In: 2011 ▪ RD Saúde was formed with the merger of two major Brazilian pharmacy chains, Raia S.A. and Drogasil S.A. ▪ It is the biggest drugstore chain in Latin America, by both revenue and market capitalization; it has 3000 pharmacies across Brazil, which offers national coverage ▪ Iconic brands Drogasil and Droga Raia are cornerstones of Brazilian Retail Market along with other exclusive brands that include Needs, NutriGood, B-Well, Natz, and CareTech ➢ Prescription Products HQ: São Paulo, Brazil ➢ OTC Medical Products Type: Private Revenue: $36.3 Bn ➢ Beauty and Health Products Website: RDSaude.com ➢ Basic Medical Supplies Recent Activity / Press Coverage ▪ July 5, 2024: Raia Drogasil announced on a 48% increase on its second-quarter adjusted net profit to 343.746 Mn reais ($66.46 Mn), boosted by higher sales ▪ April 23, 2024: Fitch Ratings assigned a Long-Term National Rating of 'AAA(bra)' to Raia Drogasil SA's (RD) proposed ninth issuance of unsecured debentures, in a single series, in the amount of up to BRL600 Mn and with final maturity in 2031 ▪ March 18, 2024: Raia Drogasil SA, a leading company in Brazilian pharmaceutical retail, announces to the market the change of its corporate brand, which will now be called RD Saúde 32 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  33. 5.2.1 RD Saúde (Continued) Latest Deals in RD Saúde Company Name Type Year Key Pointers Through its subsidiary RD Ads Ltda, Raia Drogasil acquired 100% eLoopz Serviços de Promoções de Vendas EIRELI, a tech business that specializes in media solutions for shops, got acquired as part of this deal ▪ September, 2022 Acquisition Via the acquisition, RD will be able to provide new marketing options to its 45 Mn current clients, increasing digital out-of-home advertising in its pharmacies. ▪ RD Saúde acquired Drogaria Onofre, which was previously owned by the American company CVS Health Corp ▪ February, 2019 Acquisition This acquisition solidified Raia Drogasil's (now RD Saúde) position as the leading drugstore chain in Brazil, expanding its national reach and market share ▪ Illustrative Illustrative 33 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  34. 5.2.1 RD Saúde (Continued) Revenues ($Bn), 2020-2030 Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ ▪ 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F Breakdown of Net Revenue by Segment, 2023 ▪ 1 2 3 4 Illustrative Illustrative 34 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  35. 5.2.1 Company 2 Offerings Founded In: HQ: Type: Revenue: Website: Recent Activity / Press Coverage Illustrative Illustrative 35 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  36. 5.2.1 Company 2 (Continued) Latest Deals in CompanyName Company Name Type Year Key Pointers Illustrative Illustrative 36 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  37. 5.2.1 Company 2 (Continued) Revenues ($Bn), 2020-2030 Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ ▪ 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F Breakdown of Net Revenue by Segment, 2023 ▪ 1 2 3 4 Illustrative Illustrative 37 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  38. Brazil Retail Pharmacy Market Analysis 6. Regulatory and Reimbursement Landscape

  39. 6.1 Regulatory Landscape in Brazil Regulatory Authorities With Jurisdiction Over Drugs, Biologicals, And Medical Devices In Brazil Agência Nacional de Vigilância Sanitária (ANVISA): National Health Surveillance Agency, with Ministry of Health is the regulatory body which approves a variety of products, including food, cosmetics, tobacco, medications, health services, and medical devices in Brazil Roles and Responsibilities of ANVISA: Protection of Public Health:Primary goal of the ANVISA is to protect and promote public health, by exercising health surveillance over products and services, including processes, ingredients, and technologies that pose any health risks ▪ Standardization: Another major aim of the ANVISA is to achieve legitimation in society as an integral part of the Brazilian Unified Health Systems by setting a national and international standard for health surveillance and regulation that is agile, modern, transparent, and modern ▪ Drug Registration & Licensing: It is responsible for drug registration and licensure of pharmaceutical labs and other companies inside the pharmaceutical production flow ▪ Regulations Establishment: Agency establishes regulations for clinical trials for Chemistry, Manufacturing, and Control (CMC) and subject safety through the Comitê de Ética em Pesquisa (CEP) and Comissão Nacional de Ética em Pesquisa (CONEP) ▪ Collaboration: ANVISA also works collaboratively with the Chamber of Drug Market Regulation (CDME) to regulate drug pricing and to ensure the affordability and accessibility of essential medicines for all the individuals ▪ Patent Evaluation: ANVISA evaluates patent requests related to the pharmaceutical industry in partnership with the National Industrial Property Institute ▪ Illustrative Illustrative 39 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  40. 6.2 Reimbursement Scenario in Brazil Regulatory Framework For The Authorization, Pricing, And Reimbursement Of Drugs Approval Process by ANVISA: Initially, an applicant submits a comprehensive dossier containing all necessary data including clinical and non clinical data, CMC data, quality, safety, and efficacy data • ANVISA’s technical staff, the Gerência de Ensaios Clínicos e Medicamentos (GECEP), reviews the application for completeness, accuracy, and compliance with Brazilian regulations • For certain essential drugs used to treat diseases affecting a greater number of the population in Brazil, the Chamber of Drug Market Regulation (CMED) participates in discussions regarding the drug’s value and pricing strategy • ANVISA conducts inspections of the manufacturing facilities where the drug will be produced to ensure compliance with Good Manufacturing Practices (GMP) • Based on the dossier review and any inspections, ANVISA issues a final decision, either approving the marketing authorization for the drug or outlining deficiencies that need to be addressed for approval • Review time and deadlines for ANVISA issuing a final decision regarding marketing authorization (MA) approval for drugs is 120 days for dossiers granted priority review, and 365 days for ordinary MA reviews • Illustrative Illustrative 40 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  41. 6.2 Reimbursement Scenario in Brazil (Continued) Coverage Penetration (% Total Population) Source of Funding Spend on Healthcare (%of Current Health Expenditure) 100% 100% 100% 100% 100% 44.0% Government Expenditure xx 46.0% xx 47.7% xx xx xx 51.0% 51.8% Public Healthcare Coverage Private Health Insurance Out of Pocket 38.9% 37.1% 35.6% 31.5% 32.5% Private Coverage Other NA NA 2019 2020 2021 2022 2023 2017 2018 2019 2020 2021 2022 2023  Public healthcare coverage is provided by the government and includes programs like Medicare and Medicaid  Medicare is a federal program that provides healthcare coverage to individuals who are 65 years of age or older, as well as certain younger people with disabilities 6.3% 4.08% 5.1% 3.8% 2.2% 2.4% 3.6% GDP Growth (yoy) 14.7% 11.3% 15.5% 7.5% 4.2% NA NA HC Spend Growth (yoy) Reimbursement Market Trends ▪ Shift towards value-based care has been a significant trend in Brazil healthcare system, with payers and providers increasingly focused on improving patient outcomes and reducing costs ▪ This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which incentivize providers to deliver high-quality, cost-effective care Illustrative Illustrative 41 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  42. 6.3 Reimbursement Process The reimbursement process in Brazil healthcare system can be complex and can vary depending on the type of healthcare service, the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process: Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient ▪ Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the service provided ▪ Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential errors or fraud ▪ Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service provided, based on the negotiated payment rates or fee schedule ▪ Patient Responsibility: Depending on the patient's insurance coverage, they may be responsible for paying a portion of the cost of the service, such as deductibles, co-payments, or co-insurance In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Illustrative Illustrative 42 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  43. 6.3 Reimbursement Process (Continued) The reimbursement process in Brazil healthcare system can be complex and can vary depending on the type of healthcare service, the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process: MoH Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient ▪ Market Authorization Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the service provided ▪ Private Payers Public Payers Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential errors or fraud ▪ Health Technology Assessment Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service provided, based on the negotiated payment rates or fee schedule ▪ 1 2 3 Coding Coverage Payment Coding depends on availability code while coverage and payment process decisions are made through an HTA. Illustrative Illustrative 43 A Sample Report on Brazil Retail Pharmacy Market Analysis I Confidential

  44. A division of

  45. Life-sciences Market Research Reports you can trust We maintain an extensive database comprising over 30,000 syndicated market research reports within the pharmaceuticals and healthcare sector, offering a global, regional, and country-level perspective. Our services also include the provision of customized research reports, meticulously tailored to align with your specific requirements. www.insights10.com www.insights10.com

  46. Pharma (Diseases & Drugs) Digital Health Market Research Reports across various categories in healthcare OTC & Medical Devices Nutraceuticals At Insights10, our extensive report library spans a diverse range of categories within the field of life sciences. Clinical Trials Healthcare Services Rare Diseases www.insights10.com www.insights10.com

  47. Global Coverage Europe • UK • Germany • France • Italy • Spain • Russia • Netherlands • Sweden • Romania • Switzerland • Poland • Austria • Ireland • Norway • Denmark • Belgium • Portugal • Ukraine • Bulgaria • Finland APAC • India • China • South Korea • Japan • Australia • Indonesia • Hong Kong • New Zealand • Philippines • Singapore • Malaysia • Thailand • Vietnam North America • US • Canada Africa • Egypt • Kenya • South Africa • Algeria • Nigeria • Libya • Tanzania • Morocco Middle East • UAE • Saudi Arabia • Turkey • Lebanon • Kuwait • Qatar Latin America • Brazil • Argentina • Mexico • Ecuador • Venezuela • Senegal Click on the country to see the reports available

  48. What do our reports cover? Market Overview Competitive Landscape 1 6 Growth Drivers & Growth Restraints 2 7 Policy & Regulatory Landscape Epidemiology & Disease type 3 8 Reimbursement Scenario Market Size & Forecast Recent Developments 4 9 Market Segmentation Factors Driving Future Growth 5 10

  49. Our Research Process 01 02 03 04 05 06 Define precise research questions Gather data through secondary research Validate data through primary research interviews Forecast market size and segment analysis Extract key insights from the research findings Compile & present a comprehensive analytical report

  50. Data Triangulation & Data Validation Top Down Approach Find final Examine the total healthcare expenditure in the targeted disease or service domain. market size Assess the proportion of spending allocated to the specific product or treatment category. Predict future market growth or decline based on key market trends & dynamics Predict future market growth or decline based on key market trends & dynamics Analyze product or treatment pricing and reimbursement strategies Find final market size Evaluate consumer or patient demographics and numbers Bottom Up Approach

More Related